Abstract
BackgroundFlow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology is a phosphorylcholine surface modification of the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have